Mark J. Enyedy
2020
In 2020, Mark J. Enyedy earned a total compensation of $4.6M as President and Chief Executive Officer at ImmunoGen, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $482,121 |
|---|---|
| Option Awards | $3,394,879 |
| Salary | $714,254 |
| Other | $9,372 |
| Total | $4,600,626 |
Enyedy received $3.4M in option awards, accounting for 74% of the total pay in 2020.
Enyedy also received $482.1K in non-equity incentive plan, $714.3K in salary and $9.4K in other compensation.
Rankings
In 2020, Mark J. Enyedy's compensation ranked 2,436th out of 13,090 executives tracked by ExecPay. In other words, Enyedy earned more than 81.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,436 out of 13,090 | 81st |
Division Manufacturing | 932 out of 5,621 | 83rd |
Major group Chemicals And Allied Products | 332 out of 2,254 | 85th |
Industry group Drugs | 283 out of 1,954 | 86th |
Industry Pharmaceutical Preparations | 204 out of 1,459 | 86th |
Source: SEC filing on April 28, 2021.
Enyedy's colleagues
We found four more compensation records of executives who worked with Mark J. Enyedy at ImmunoGen in 2020.